Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects

Clinical trial NCT01751269 · COMPLETED

Trial details

NCT number: NCT01751269
Sponsor: Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Bacterial Infections

Start date: 2012-12-01
Primary completion: 2013-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.